310 related articles for article (PubMed ID: 15142055)
21. Conversion to sirolimus-based maintenance immunosuppression using daclizumab bridge therapy in renal transplant recipients.
Sundberg AK; Rohr MS; Hartmann EL; Adams PL; Stratta RJ
Clin Transplant; 2004; 18 Suppl 12():61-6. PubMed ID: 15217410
[TBL] [Abstract][Full Text] [Related]
22. Prevalence and implications of isolated microscopic hematuria in asymptomatic Chinese pregnant women.
Szeto CC; To KF; Lai FM; Chow KM; Tam WH; Chung KY; Leung CB; Lui SF; Li PK; Lau TK
Nephron Clin Pract; 2007; 105(4):c147-52. PubMed ID: 17259739
[TBL] [Abstract][Full Text] [Related]
23. The fate of glomerular mesangial IgA deposition in the donated kidney after allograft transplantation.
Ji S; Liu M; Chen J; Yin L; Sha G; Chen H; Liu Z; Li L
Clin Transplant; 2004 Oct; 18(5):536-40. PubMed ID: 15344956
[TBL] [Abstract][Full Text] [Related]
24. Proteinuria after kidney transplantation: its relation to hepatitis C virus and graft outcome.
Sabry A; Hassan R; Mahmoud I; Hamed M; Sobh M
Iran J Kidney Dis; 2007 Oct; 1(2):88-97. PubMed ID: 19363283
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
[TBL] [Abstract][Full Text] [Related]
26. [Predisposing factors for ureteric strictures in renal transplantation].
Hétet JF; Rigaud J; Gignoux A; Le Normand L; Glémain P; Bouchot O; Karam G
Prog Urol; 2005 Jun; 15(3):462-71. PubMed ID: 16097152
[TBL] [Abstract][Full Text] [Related]
27. Achieving chronic kidney disease treatment targets in renal transplant recipients: results from a cross-sectional study in Spain.
Marcén R; del Castillo D; Capdevila L; Fernandez-Fresnedo G; Rodrigo E; Cantarell C; Fernández-Rodriguez A; López-Oliva MO; Camps J; Aljama P; Ortuño J; Arias M
Transplantation; 2009 May; 87(9):1340-6. PubMed ID: 19424034
[TBL] [Abstract][Full Text] [Related]
28. Glomerular crescents are responsible for chronic graft dysfunction in post-transplant IgA nephropathy.
Jeong HJ; Kim YS; Kwon KH; Kim SI; Kim MS; Choi KH; Lee HY; Han DS; Park K
Pathol Int; 2004 Nov; 54(11):837-42. PubMed ID: 15533226
[TBL] [Abstract][Full Text] [Related]
29. Impact of metabolic syndrome on graft function and survival after cadaveric renal transplantation.
Porrini E; Delgado P; Bigo C; Alvarez A; Cobo M; Checa MD; Hortal L; Fernández A; García JJ; Velázquez S; Hernández D; Salido E; Torres A
Am J Kidney Dis; 2006 Jul; 48(1):134-42. PubMed ID: 16797396
[TBL] [Abstract][Full Text] [Related]
30. Influence of interleukin-10 gene G-1082A polymorphism on recurrent IgA nephropathy.
Bantis C; Heering PJ; Aker S; Schwandt C; Grabensee B; Ivens K
J Nephrol; 2008; 21(6):941-6. PubMed ID: 19034880
[TBL] [Abstract][Full Text] [Related]
31. Impact of chronic allograft nephropathy and subsequent modifications of immunosuppressive therapy on late graft outcomes in renal transplantation.
Montagnino G; Banfi G; Campise MR; Passerini P; Aroldi A; Cesana BM; Ponticelli C
Nephrol Dial Transplant; 2004 Oct; 19(10):2622-9. PubMed ID: 15316096
[TBL] [Abstract][Full Text] [Related]
32. Persistent cytomegalovirus infection in kidney allografts is associated with inferior graft function and survival.
Helanterä I; Koskinen P; Finne P; Loginov R; Kyllönen L; Salmela K; Grönhagen-Riska C; Lautenschlager I
Transpl Int; 2006 Nov; 19(11):893-900. PubMed ID: 17018124
[TBL] [Abstract][Full Text] [Related]
33. Bladder carcinoma among live-donor renal transplant recipients: a single-centre experience and a review of the literature.
Kamal MM; Soliman SM; Shokeir AA; Abol-Enein H; Ghoneim MA
BJU Int; 2008 Jan; 101(1):30-5. PubMed ID: 17850360
[TBL] [Abstract][Full Text] [Related]
34. The influence of hepatitis B and hepatitis C virus infection in the recipient on late renal allograft failure.
Morales JM; Domínguez-Gil B; Sanz-Guajardo D; Fernández J; Escuin F
Nephrol Dial Transplant; 2004 Jun; 19 Suppl 3():iii72-6. PubMed ID: 15192141
[TBL] [Abstract][Full Text] [Related]
35. Adverse impact of pretransplant polyoma virus infection on renal allograft function.
Hayat A; Mukhopadhyay R; Radhika S; Sachdeva MS; Nada R; Joshi K; Sakhuja V; Jha V
Nephrology (Carlton); 2008 Apr; 13(2):157-63. PubMed ID: 18275505
[TBL] [Abstract][Full Text] [Related]
36. Transplanting kidneys from CMV-seropositive donors to CMV-seronegative recipients is not associated with poorer renal allograft function or survival.
McLaughlin K; Sandhu S; Wu C; Muirhead N; Hollomby D; Jevnikar A
Nephrol Dial Transplant; 2005 Jan; 20(1):176-80. PubMed ID: 15572381
[TBL] [Abstract][Full Text] [Related]
37. Pediatric renal transplantation: comparative study with renal transplantation in the adult population.
Parada B; Figueiredo A; Nunes P; Bastos C; Macário F; Roseiro A; Dias V; Rolo F; Mota A
Transplant Proc; 2005; 37(6):2771-4. PubMed ID: 16182806
[TBL] [Abstract][Full Text] [Related]
38. Early acute rejection does not affect chronic allograft nephropathy and death censored graft failure.
He X; Johnston A
Transplant Proc; 2004 Dec; 36(10):2993-6. PubMed ID: 15686679
[TBL] [Abstract][Full Text] [Related]
39. Tacrolimus as secondary intervention vs. cyclosporine continuation in patients at risk for chronic renal allograft failure.
Waid T;
Clin Transplant; 2005 Oct; 19(5):573-80. PubMed ID: 16146546
[TBL] [Abstract][Full Text] [Related]
40. Posttransplant proteinuria is associated with higher risk of cardiovascular disease and graft failure in renal transplant patients.
Ibis A; Akgül A; Ozdemir N; Colak T; Sezer S; Arat Z; Haberal M
Transplant Proc; 2009 Jun; 41(5):1604-8. PubMed ID: 19545689
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
